The broad-based selling by asset managers contrasts with a single quant buyer. Track Q4 2024 13F filings for further follow-through selling. Also monitor ZLAB's upcoming earnings for fundamental catalysts that may explain the exits.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $17.64entry
- T+1 · 5mo ago −3.23%α −3.77% · $17.07
- T+5 · 5mo ago +1.36%α +0.93% · $17.88
- T+20 · 4mo ago +13.27%α +11.37% · $19.98
- T+60 · 2mo ago +48.70%α +44.30% · $26.23
How similar events traded
Executive Summary
Institutional cluster for ZLAB (Zai Lab) shows a bearish tilt with 4 sellers versus 1 buyer in Q3 2024. Two asset managers (Capital International and Mirae Asset) executed near-full exits, reducing combined holdings by ~$11.9M. Citadel added $16.7M, partially offsetting the selling, but the breadth and conviction of the sellers suggests fundamental concerns among fundamentally-oriented managers.
Key Financial Metrics
Institutional Positions
Net institutional flow: $4.5M
▲ Buyers (1)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Citadel | ADD | +48.5% | $32.3M | $16.7M |
▼ Sellers (4)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| D.E. Shaw | TRIM | -49.2% | $302.0K | -$88.0K |
| Legal & General Group | TRIM | -34.5% | $2.7M | -$238.0K |
| Capital International Investor | NEAR_EXIT | -82% | $14.0M | -$10.5M |
| Mirae Asset Global Investments | NEAR_EXIT | -94.8% | $1.5M | -$1.4M |
Key Facts
- 4 institutional sellers vs. 1 buyer in Q3 2024
- Capital International near-exited 82% of its stake, selling ~$10.5M worth of shares
- Mirae Asset Global Investments near-exited 94.8%, selling ~$1.4M
- Citadel (quant) added 48.5% to its position, now holding $32.3M
- Total tracked net dollar change: +$4.5M (buying $16.7M vs. selling $12.2M) but breadth is clearly bearish
Financial Impact
Aggregate institutional activity: buyers added $16.7M in new shares, sellers reduced holdings by $12.2M, resulting in a net inflow of ~$4.5M from tracked funds this quarter. However, the number and type of sellers (two asset manager near-exits) dominate the signal.
Risk Factors
- Continued institutional outflow if fundamental headwinds persist
- Sole buyer (Citadel) may unwind quant position rapidly
- China biotech regulatory risks and reimbursement uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ZLAB-2024-Q3 |
Track record
23 reports on ZLAB
2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Viewing Entry $17.64 to $17.07 ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers